Compare Exelixis Inc. Common Stock (EXEL) vs Invesco NASDAQ 100 ETF (QQQM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Exelixis Inc. Common Stock vs Invesco NASDAQ 100 ETF — how do they compare? Exelixis Inc. Common Stock trades at $60.43 (market cap $14.62B), while Invesco NASDAQ 100 ETF trades at $308.99 (market cap $113.40B). The key difference: Invesco NASDAQ 100 ETF is far larger — about 7.8× Exelixis Inc. Common Stock's market cap, and Invesco NASDAQ 100 ETF is more actively traded (2,866,236 versus 2,684,957). Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 0 Days and Invesco NASDAQ 100 ETF for 54 Days on average.
| EXEL | QQQM | |
|---|---|---|
Market Cap | $14.62B | $113.40B |
Volume | 2,684,957 | 2,866,236 |
Sector | Health | Broad Market / Factor |
52-Week High | $59.13 | $312.76 |
52-Week Low | $34.54 | $229.87 |
Typical Hold Time | 0 Days | 54 Days |
Enterprise Value | $13.95B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
QQQM trades at $308.42, down 1.15% on the day, while maintaining a bullish technical outlook with strong moving average support. The ETF's lower 0.15% expense ratio compared to QQQ's 0.18% provides a cost advantage, though trading spreads can impact returns. Recent institutional buying includes QRG Capital Management increasing its position by 207.5% during Q2 2026, signaling confidence in the Nasdaq-100 exposure.
The ETF offers pure Nasdaq-100 exposure with competitive fees, though investors should be aware of concentration risk in technology stocks and potential tax implications of distributions. Technical indicators suggest near-term support at $305 with resistance at $311, while institutional accumulation supports the bullish case for long-term growth investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Exelixis Inc. Common Stock
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →About Invesco NASDAQ 100 ETF
QQQM is an ETF designed to track the performance of the NASDAQ-100 Index. It provides exposure to the 100 largest non-financial companies listed on the NASDAQ. Positioned as a lower-cost and more long-term-investor-friendly alternative to its peer QQQ, QQQM offers the same fundamental market exposure but typically has a lower share price and is structured to appeal to investors focused on accumulation rather than active trading.
Read more on QQQM →
